The Lilac2 trial which was by invitation now no longer recruits, the patients initially expected were 153 but 78 were effective:
https://clinicaltrials.gov/ct2/history/NCT04776746?A=21&B=22&C=merged#StudyPageTop
Acadia's 2 trials on irritability associated with autism spectrum disorder are advancing fast and recruiting also in Europe:
https://clinicaltrials.gov/ct2/show/NCT05523895?term=Pimavanserin&draw=2&rank=5
https://clinicaltrials.gov/ct2/show/NCT05555615?term=Pimavanserin&draw=2&rank=1
Happy Easter everyone
Acadia, page-244
-
- There are more pages in this discussion • 434 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$13.38 |
Change
-0.270(1.98%) |
Mkt cap ! $1.710B | |||
| Open | High | Low | Value | Volume |
| $13.68 | $13.68 | $13.11 | $4.283M | 320.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 25 | $13.34 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $13.40 | 3328 | 3 |
View Market Depth
| Last trade - 16.10pm 18/09/2024 (20 minute delay) ? |
| NEU (ASX) Chart |